Dr. Reddy's Laboratories Limited
JPMorgan decreased its stake in Dr. Reddy's Laboratories Limited from 11.94% to 11.41%. While the exact number of shares and value for this transaction are not available, other sources indicate JPMorgan sold 130,856 shares in June 2020 for ₹11.2 crore.
A leading India-based pharmaceutical company, Dr Reddy's Laboratories manufactures and distributes Active Pharmaceutical Ingredients, generic medicines, biosimilars, and differentiated formulations across multiple therapeutic areas. The company operates custom pharmaceutical services and serves patients in markets worldwide. Its integrated operations span drug discovery, development, manufacturing, and commercialization of innovative and generic pharmaceuticals for diverse healthcare needs.
US-based global investment bank. India FPI activity covers proprietary, market-making and client flows in listed Indian equities.